These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 817644)

  • 41. Frequency and resistance patterns of bacterial isolates from surgical patients in a teaching hospital in Addis Ababa.
    Gedebou M; Tassew A; Azene G
    Trop Geogr Med; 1983 Jun; 35(2):133-8. PubMed ID: 6351382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Susceptibility to antimicrobial agents of 2,060 strains of different bacteria isolated in infectious processes in children].
    Filloy L; Borjas E; Sierra A
    Bol Med Hosp Infant Mex; 1981; 38(1):13-21. PubMed ID: 7025858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-resistance between some aminoglycoside antibiotics.
    Onaolapo JA
    Afr J Med Med Sci; 1994 Sep; 23(3):215-9. PubMed ID: 7604744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Determination of serum aminoglycoside and vancomycin concentrations by the microbiological method in the presence of other antimicrobials].
    Corso A; Galas MF; Rossi MA
    Rev Argent Microbiol; 1996; 28(3):123-31. PubMed ID: 9026822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial resistance and conjugative R plasmids in Escherichia coli strains isolated from animals in Peninsular Malaysia.
    Koh CL; Kok CH
    Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):37-43. PubMed ID: 6377513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Variability of bacterial flora and of its resistance to antibiotics in 1962-1964 and in 1966-1967].
    Zuber E; Woźniak-Zuber H
    Pol Tyg Lek; 1969 Jan; 24(3):89-91. PubMed ID: 4896576
    [No Abstract]   [Full Text] [Related]  

  • 47. Sensitivity of Staphylococcus aureus and Escherichia coli to antibiotics. V. Differentiation of drug sensitive- and resistant-strains by minimal inhibitory concentration of the drug and annual change of sensitivity of the bacteria to various drugs.
    Otaya H
    J Antibiot (Tokyo); 1974 Sep; 27(9):686-95. PubMed ID: 4611992
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of biologically active substances on Escherichia coli chloramphenicol acetyltransferase activity].
    Solov'eva NN; Belousova II; Tereshin IM
    Antibiotiki; 1979 Jun; 24(6):436-40. PubMed ID: 378112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial resistance to the synergistic antibiotics of the PA 114, streptogramin, and vernamycin complexes.
    Ennis HL
    J Bacteriol; 1967 Jun; 93(6):1881-7. PubMed ID: 4960896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Action of EDTA-Tris and antimicrobial agent combinations on selected pathogenic bacteria.
    Wooley RE; Jones MS
    Vet Microbiol; 1983 Jun; 8(3):271-80. PubMed ID: 6412426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug resistance patterns and susceptibility to aflatoxin B1 of strains of Escherichia coli and Staphylococcus aureus.
    Tiwari RP; Singh G; Vadehra DV
    J Med Microbiol; 1986 Sep; 22(2):115-8. PubMed ID: 3091837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Biochemical processes in the leukocytes which phagocytize antibiotic--sensitive and antibiotic-resistant bacteria].
    Tsyganenko AIa; Balakliets NI
    Antibiotiki; 1975; 20(12):1107-11. PubMed ID: 773285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Development of resistance to difuracil (PAP-49) in bacteria and its activity in combination with other antibacterial drugs].
    Pavlov PA
    Antibiot Khimioter; 1997; 42(8):34-7. PubMed ID: 9412411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro effect of edta-tris-lysozyme solutions on selected pathogenic bacteria.
    Wooley RE; Blue JL
    J Med Microbiol; 1975 Feb; 8(1):189-94. PubMed ID: 805241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On structural damage incurred by bacteria upon exposure to hydrophobic polycationic coatings.
    Hsu BB; Ouyang J; Wong SY; Hammond PT; Klibanov AM
    Biotechnol Lett; 2011 Feb; 33(2):411-6. PubMed ID: 20882318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sensitivity of Gram-negative microflora to lysozyme].
    Ved'mina EA; Pasternak NA; Shenderovich VA; Zhuravleva TP; Andrusenko IT
    Antibiotiki; 1979 Oct; 24(10):746-50. PubMed ID: 386935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of constant and increasing concentrations of antibiotics on the level of resistance in Escherichia coli].
    Kynina OS
    Mikrobiol Zh; 1978; 40(4):506-7. PubMed ID: 364251
    [No Abstract]   [Full Text] [Related]  

  • 58. Factors that may prevent transfer of anti-biotic resistance between gram-negative bacteria in the gut.
    Anderson JD
    J Med Microbiol; 1975 Feb; 8(1):83-8. PubMed ID: 805244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Prymnesium parvum toxin, cetyltrimethylammonium bromide and sodium dodecyl sulphate on bacteria.
    Ulitzur S; Shilo M
    J Gen Microbiol; 1970 Aug; 62(3):363-70. PubMed ID: 4992994
    [No Abstract]   [Full Text] [Related]  

  • 60. Antibacterial and antitumor activity of some derivatives of ureidosuccinic acid.
    Golovinsky EV; Maneva LS; Angelov II; Veljanova KD; Sniker DJ; Stankevich EK
    Neoplasma; 1976; 23(1):43-6. PubMed ID: 131912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.